Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase II Randomized Trial of Neoadjuvant Chemotherapy or Chemo-Immunotherapy in Patients With Recurrent/Persistent PD-L1 Enriched Squamous Cell Carcinoma of the Head and Neck Undergoing Salvage Surgery NEOPOLIS
Study Type: Treatment
Phase: II
NCTID: NCT07195734
Principal Investigator:
Omar Karadaghy
TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients with Head Neck Squamous Cell Carcinoma HNSCC
Study Type: Other
Phase: N/A
NCTID: NCT06163534
Principal Investigator:
Prakash Neupane
COMETH Study: Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head Neck Oncology
Study Type: Other
Phase: N/A
NCTID: NCT07550049
Principal Investigator:
Chao Huang
A Phase 2 Study Using Chemoimmunotherapy with Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma NPC
Study Type: Treatment
Phase: II
NCTID: NCT06064097
Principal Investigator:
Keith August
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Study Type: Treatment
Phase: II/III
NCTID: NCT01810913
Principal Investigator:
Chris Lominska
A Multicenter, Randomized, Double-Blind, Phase II/III Study of BCA101 or Placebo in Combination with Pembrolizumab for First Line Treatment of PD-L1-positive, Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Study Type: Treatment
Phase: II/III
NCTID: NCT06788990
Principal Investigator:
Prakash Neupane
A Randomized, Masked, Placebo Controlled, Phase II Trial of Concurrent Chemoradiation with BMX-001 in Patients with Head and Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation
Study Type: Supportive Care
Phase: II
NCTID: NCT06532279
Principal Investigator:
Chris Lominska
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Phase III Study of Ficlatuzumab in Combination with Cetuximab in Participants with Recurrent or Metastatic R/M HPV-Negative Head and Neck Squamous Cell Carcinoma FIERCE-HN
Study Type: Treatment
Phase: III
NCTID: NCT06064877
Principal Investigator:
Prakash Neupane
Implementing the NYU Electronic Patient Visit Assessment ePVA for Head and Neck Cancer In Rural and Urban Populations
Study Type: Supportive Care
Phase: N/A
NCTID: NCT06030011
Principal Investigator:
Chris Lominska
Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Platinum Refractory Disease.
Study Type: Treatment
Phase: III
NCTID: NCT06589804
Principal Investigator:
Prakash Neupane